FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Aortic Valve, Prosthesis, Percutaneously Delivered
PMA: P130021
·
Supplement: S051
·
Decision Aug 24, 2018
Classifications
1
FEI Numbers
24
Registration Numbers
24
Basic Information
- Device Name
- Aortic Valve, Prosthesis, Percutaneously Delivered
- Trade Name
- CoreValve Evolut R System and CoreValve Evolut PRO System
- PMA Number
- P130021
- Supplement Number
- S051
- Device Class
- FDA Class 3
- Product Code
- NPT
- Generic Name
- Aortic valve, prosthesis, percutaneously delivered
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- August 24, 2018
- Date Received
- June 29, 2018
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
Approval for modifying the labeling to remove the precaution regarding patients with a congenital bicuspid aortic valve.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NPT | Aortic Valve, Prosthesis, Percutaneously Delivered | FDA class 3 | Unknown |